Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_assertion type Assertion NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_head.
- NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_assertion description "[Moreover, TF overexpression accompanies features of cellular aggressiveness such as markers of CSCs (CD133), epithelial-to-mesenchymal transition (EMT) and expression of the angiogenic and prometastatic phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_provenance.
- NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_assertion evidence source_evidence_literature NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_provenance.
- NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_assertion SIO_000772 20434004 NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_provenance.
- NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_assertion wasDerivedFrom befree-20140225 NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_provenance.
- NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_assertion wasGeneratedBy ECO_0000203 NP402215.RApWIRuI-QN2H5DDi5EdprvGE_O8a601S5tIYUfPNfKcQ130_provenance.